Acta pharmacologica et toxicologica最新文献

筛选
英文 中文
Abstracts I. III World Conference on Clinical Pharmacology & Therapeutics. Stockholm, July 27-August 1, 1986. 世界临床药理学与治疗学会议。1986年7月27日至8月1日,斯德哥尔摩。
Acta pharmacologica et toxicologica Pub Date : 1986-01-01
{"title":"Abstracts I. III World Conference on Clinical Pharmacology & Therapeutics. Stockholm, July 27-August 1, 1986.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":6972,"journal":{"name":"Acta pharmacologica et toxicologica","volume":"59 Suppl 5 Pt 1 ","pages":"1-224"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14883637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstracts II. III World Conference on Clinical Pharmacology & Therapeutics. Stockholm, July 27-August 1, 1986. 摘要二世。第三届世界临床药理学与治疗学会议。1986年7月27日至8月1日,斯德哥尔摩。
Acta pharmacologica et toxicologica Pub Date : 1986-01-01
{"title":"Abstracts II. III World Conference on Clinical Pharmacology & Therapeutics. Stockholm, July 27-August 1, 1986.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":6972,"journal":{"name":"Acta pharmacologica et toxicologica","volume":"59 Suppl 5 Pt 2 ","pages":"1-342"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14883639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of ergotamine on the arterial system in man. 麦角胺对人体动脉系统的影响。
Acta pharmacologica et toxicologica Pub Date : 1986-01-01
P Tfelt-Hansen
{"title":"The effect of ergotamine on the arterial system in man.","authors":"P Tfelt-Hansen","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":6972,"journal":{"name":"Acta pharmacologica et toxicologica","volume":"59 Suppl 3 ","pages":"1-30"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14220688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstracts I. III World Conference on Clinical Pharmacology & Therapeutics. Stockholm, July 27-August 1, 1986. 世界临床药理学与治疗学会议。1986年7月27日至8月1日,斯德哥尔摩。
Acta pharmacologica et toxicologica Pub Date : 1986-01-01 DOI: 10.1111/j.1600-0773.1986.tb02696.x
{"title":"Abstracts I. III World Conference on Clinical Pharmacology & Therapeutics. Stockholm, July 27-August 1, 1986.","authors":"","doi":"10.1111/j.1600-0773.1986.tb02696.x","DOIUrl":"https://doi.org/10.1111/j.1600-0773.1986.tb02696.x","url":null,"abstract":"","PeriodicalId":6972,"journal":{"name":"Acta pharmacologica et toxicologica","volume":"31 1","pages":"1-224"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74306413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early abnormalities in myocardial cell function in experimental diabetes. 实验性糖尿病患者心肌细胞功能早期异常。
Acta pharmacologica et toxicologica Pub Date : 1986-01-01
O Gøtzsche
{"title":"Early abnormalities in myocardial cell function in experimental diabetes.","authors":"O Gøtzsche","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":6972,"journal":{"name":"Acta pharmacologica et toxicologica","volume":"59 Suppl 2 ","pages":"1-21"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14150906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical pharmacological aspects on nitrate tolerance. 硝酸盐耐受性的临床药理学研究。
Acta pharmacologica et toxicologica Pub Date : 1986-01-01
B Beermann
{"title":"Clinical pharmacological aspects on nitrate tolerance.","authors":"B Beermann","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>There is strong evidence that nitrate tolerance develops rapidly during repeated administration in the systemic resistance vascular bed and that there exists cross tolerance between different nitrates. There are divergent opinions on how tolerance in the systemic capacitance and the pulmonary vascular bed develops. This may be explained by real differences in tolerance development in ischemic heart disease and congestive heart failure but also by the use of several different preparations of nitrates in the studies performed. Available data on the pharmacokinetics of nitrates present a complex picture with highly variable bioavailability, clearance and apparent volume of distribution both inter- and intraindividually. It is suggested that nitrate tolerance should be studied in very homogeneous groups of patients with well defined hemodynamics. The nitrate used should have a very short half-life allowing for simulation of various modes of administration by intravenous infusion.</p>","PeriodicalId":6972,"journal":{"name":"Acta pharmacologica et toxicologica","volume":"59 Suppl 6 ","pages":"35-9"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14661747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
On calcium and calcium channel blockade. 对钙和钙通道的阻断。
Acta pharmacologica et toxicologica Pub Date : 1986-01-01
{"title":"On calcium and calcium channel blockade.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":6972,"journal":{"name":"Acta pharmacologica et toxicologica","volume":"58 Suppl 2 ","pages":"1-204"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13571591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
On the muscarinic receptors in the urinary bladder and the putative subclassification of muscarinic receptors. 膀胱中毒蕈碱受体及毒蕈碱受体的推定亚分类。
Acta pharmacologica et toxicologica Pub Date : 1986-01-01
L Nilvebrant
{"title":"On the muscarinic receptors in the urinary bladder and the putative subclassification of muscarinic receptors.","authors":"L Nilvebrant","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The muscarinic cholinergic receptors in the urinary bladders of man, guinea pig, rat and rabbit were studied by means of a receptor binding technique, with l-quinuclidinyl [phenyl 4-3H]benzilate, (-)3H-QNB, as radioligand. The potential role of the receptors in the supersensitivity of the rat bladder to muscarinic agonists, following parasympathetic denervation, hypertrophy and urinary diversion, was also investigated. In addition, the binding of various unlabelled antimuscarinic drugs in the guinea pig bladder was compared to that in other tissues in order to study the putative muscarinic receptor subtypes, commonly referred to as M1 and M2. According to this classification the putative M1 receptors prevail in discrete areas of the brain, whereas the M2-receptors predominate in peripheral tissues, such as the exocrine glands and smooth muscles. The receptor density (but not the qualitative properties of the receptors) in the bladder differed between the species. The affinities of various antimuscarinic drugs were virtually identical in the guinea pig and human bladders. In both species, the binding data were found to correlate with functional in vitro data. In the rat bladder, the receptor density was increased after denervation but decreased, below control values, when the denervation was combined with urinary diversion. A decrease was also found after urinary diversion of innervated bladders, whereas the receptor density was unaffected by hypertrophy. These results suggest that the receptors are not involved in the development of supersensitivity and that the receptor levels may be influenced by the functional state of the bladder. Binding studies with classical muscarinic antagonists indicated that the receptors in the guinea pig bladder are indistinguishable from those in the ileum, heart, parotid gland and cerebral cortex. However, four drugs--namely, oxybutynin, dicyclomine, benzhexol and pirenzepine had a much higher affinity for the receptors in the parotid gland and cortex than for those in the other tissues. Moreover, dicyclomine and benzhexol, like pirenzepine, seemed in the cortex to distinguish between two classes of sites exhibiting high and low affinity. The high affinity sites could be selectively labelled with 3H-benzhexol. The ability of oxybutynin, dicyclomine, benzhexol and pirenzepine to discriminate between the receptors in the parotid gland and those in smooth muscle provides further evidence that the M1/M2 concept is inaccurate. The present data indicate that there may be three classes of muscarinic antagonist binding sites.</p>","PeriodicalId":6972,"journal":{"name":"Acta pharmacologica et toxicologica","volume":"59 Suppl 1 ","pages":"1-45"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14645971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exercise testing in patients with heart disease. 心脏病患者的运动试验
Acta pharmacologica et toxicologica Pub Date : 1986-01-01
H Aström
{"title":"Exercise testing in patients with heart disease.","authors":"H Aström","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Exercise tests performed in the clinic give important qualitative and quantitative information. Psychological scaling of main symptoms is most valuable to define a patient's incapacitation and maximal performance. In pharmacological testing this is of utmost importance, particularly in patients with angina pectoris or heart failure. In chronic heart failure there is a poor correlation between the maximal working capacity and the performance of the heart.</p>","PeriodicalId":6972,"journal":{"name":"Acta pharmacologica et toxicologica","volume":"59 Suppl 6 ","pages":"65-70"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14906554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acetohydroxamate, a urease inhibitor, inhibits the covalent binding reaction of complement proteins C3 and C4. 乙酰羟酸酯是脲酶抑制剂,抑制补体蛋白C3和C4的共价结合反应。
Acta pharmacologica et toxicologica Pub Date : 1985-10-01 DOI: 10.1111/j.1600-0773.1985.tb00048.x
E Sim, A Jones, L Stanley
{"title":"Acetohydroxamate, a urease inhibitor, inhibits the covalent binding reaction of complement proteins C3 and C4.","authors":"E Sim,&nbsp;A Jones,&nbsp;L Stanley","doi":"10.1111/j.1600-0773.1985.tb00048.x","DOIUrl":"https://doi.org/10.1111/j.1600-0773.1985.tb00048.x","url":null,"abstract":"","PeriodicalId":6972,"journal":{"name":"Acta pharmacologica et toxicologica","volume":"57 4","pages":"304-6"},"PeriodicalIF":0.0,"publicationDate":"1985-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1600-0773.1985.tb00048.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15194598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信